Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» orforglipron
orforglipron
Lilly links oral obesity drug to 15% weight loss, setting bar for Pfizer in blockbuster battle
Lilly links oral obesity drug to 15% weight loss, setting bar for Pfizer in blockbuster battle
Fierce Biotech
Eli Lilly
obesity
orforglipron
Pfizer
Novo Nordisk
Mounjaro
Flag link:
ADA 2023 preview – Lilly’s oral obesity data leave room for Pfizer
ADA 2023 preview – Lilly’s oral obesity data leave room for Pfizer
EP Vantage
ADA
Eli Lilly
Pfizer
diabetes
obesity
orforglipron
danuglipron
lotiglipron
Flag link:
Lilly steps up its oral obesity push
Lilly steps up its oral obesity push
EP Vantage
Eli Lilly
obesity
GLP-1 agonist
orforglipron
Flag link:
Lilly and Pfizer fight for new territory in obesity and diabetes
Lilly and Pfizer fight for new territory in obesity and diabetes
EP Vantage
Eli Lilly
Pfizer
obesity
diabetes
orforglipron
Mounjaro
Flag link:
